SCHEMBL24071963

SCHEMBL24071963

CCC1CC(Nc2nc(Nc3cc(C)[nH]n3)c3sccc3n2)CC(CC)N1C(=O)c1nccn1C

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ PAK1 Q13153 3/20 0.43
▸ JAK2 O60674 9/20 0.38
▸ PAK4 O96013 2/20 0.38
▸ DYRK3 O43781 1/20 0.38
▸ PRKD3 O94806 1/20 0.38
▸ MAP4K4 O95819 1/20 0.38
▸ ABL1 P00519 1/20 0.38
▸ LCK P06239 1/20 0.38
▸ FYN P06241 1/20 0.38
▸ CSF1R P07333 1/20 0.38
▸ RET P07949 1/20 0.38
▸ IGF1R P08069 1/20 0.38
▸ MET P08581 1/20 0.38
▸ ROS1 P08922 1/20 0.38
▸ FGFR1 P11362 1/20 0.38
▸ PRKACA P17612 1/20 0.38
▸ FLT1 P17948 1/20 0.38
▸ FGFR3 P22607 1/20 0.38
▸ KDR P35968 1/20 0.38
▸ SYK P43405 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL23889609 0.89 PAK4 (0.37) JAK2PAK4TYK2JAK3JAK1
SCHEMBL22054002 0.89 PAK1 (0.45) PAK1JAK2PAK4DYRK3PRKD3
SCHEMBL23878799 0.89 PAK1 (0.45) PAK1JAK2PAK4DYRK3PRKD3
SCHEMBL24995571 0.86 PAK1 (0.44) PAK1JAK2PAK4DYRK3PRKD3
SCHEMBL22054622 0.85 PAK1 (0.43) PAK1JAK2PAK4DYRK3PRKD3
SCHEMBL23889633 0.80 PAK1 (0.45) PAK1JAK2PAK4DYRK3PRKD3
SCHEMBL22054104 0.78 PAK1 (0.47) PAK1JAK2PAK4DYRK3PRKD3
SCHEMBL22054952 0.77 TYK2 (0.45) JAK2PAK4TYK2JAK3JAK1
SCHEMBL30255561 0.77 TYK2 (0.45) JAK2PAK4TYK2JAK3JAK1
SCHEMBL30255579 0.77 PAK1 (0.53) PAK1JAK2PAK4DYRK3PRKD3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2021238908-A1 SALT AND CRYSTAL FORM OF HETEROARYL DERIVATIVE, AND PREPARATION METHOD THEREFOR 上海翰森生物医药科技有限公司 2021-12-02 — — WO disclosed
Send feedback